Switch to:
More From Other Websites
Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular Disease... Mar 08 2017
Acasti Pharma Grants Incentive Stock and Options Feb 24 2017
Neptune to Present at ROTH Capital Partners 29th Annual Growth Stock Conference Feb 22 2017
Acasti Pharma Announces Proposed Private Placement of Convertible Debentures and Amended Proposed... Feb 02 2017
Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q3, 2017 By the Numbers :... Jan 18 2017
Neptune Tech posts 3Q profit Jan 12 2017
Neptune Tech posts 3Q profit Jan 12 2017
Acasti Pharma Reports Third Quarter 2017 Financial Results Jan 12 2017
Neptune Announces Record Third Quarter Results Jan 12 2017
Neptune to Hold Conference Call to Discuss Third Quarter Results for the Period Ended November 30,... Jan 04 2017
Neptune to Hold Conference Call to Discuss Third Quarter Results for the Period Ended November 30,... Jan 04 2017
Validity of Neptune’s Patent Upheld by Australian Patent Office / Third Challenge by Enzymotec... Nov 08 2016
Neptune Announces Stock Ticker Symbol Change to NEPT on the TSX Nov 08 2016
Validity of Neptune's Patent Upheld by Australian Patent Office Nov 07 2016
Neptune Announces Stock Ticker Symbol Change to NEPT on the TSX Nov 04 2016
Acasti Announces Stock Ticker Symbol Change to ACST on the TSXV Nov 03 2016
Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre Oct 26 2016
Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q2, 2017 By the Numbers :... Oct 18 2016
Neptune Announces Q2 FY 2017 Results Oct 12 2016
Neptune Announces Second Quarter Results Oct 12 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK